If you missed any, thankfully, you're in luck — the Buccaneers' social media account posted every sack Tampa Bay has gotten this year, and you can check out the video down below: Leading the ...

Ex-Rangers manager Steven Gerrard will remain in charge of Al-Ettifaq despite his side's poor start to the season. However, executive sporting director Mark Allen and assistant manager Dean Holden ...

Steven Gerrard will reportedly stay on as Al-Ettifaq manager after showdown talks with club bosses. Friday's 3-1 defeat to leaders Al-Hilal made it seven Saudi Pro League games without a win for ...

Roma have sacked head coach Ivan Juric following Sunday's 3-2 home defeat by Bologna and are searching for their third manager of the season. Croatian Juric, 49, was appointed in September as a ...

Al-Ettifaq have been told it would be embarrassing for the Saudi Pro League if they were to sack Steven Gerrard. The pressure is mounting on the Liverpool great after his side were beaten again on ...

Warren Gatland admitted on Wednesday that he had not yet given any thought to resigning as Wales head coach, but said he would ‘go back to the beach and have a glass of wine’ if his Welsh ...

Saudi Arabia could offer an escape route for David Coote – should the under-fire referee end up with the sack. Officials from refs’ body PGMOL are continuing to investigate the 42-year-old ...

HENDERSON, Nev., November 14, 2024--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for ...

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio ...

Zura Bio Limited ( (ZURA)) has released its Q3 earnings. Here is a breakdown of the information Zura Bio Limited presented to its investors. Zura Bio Limited is a clinical-stage immunology company ...

NASDAQ ZURA opened at $4.38 on Monday. Zura Bio has a 12-month low of $2.00 and a 12-month high of $6.35. The company has a fifty day simple moving average of $4.21 and a two-hundred day simple ...

Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today ...